California State Teachers Retirement System Eagle Pharmaceuticals, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.26 - $6.51 $2,824 - $4,316	-663 Reduced 38.93%	1,040 $5,000
Q4 2023 Feb 13, 2024	SELL	$4.63 - $15.21 $2,685 - $8,821	-580 Reduced 25.41%	1,703 $8,000
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $175,173 - $263,508	-11,517 Reduced 83.46%	2,283 $36,000
Q2 2023 Aug 21, 2023	SELL	$17.74 - $31.87 $5,233 - $9,401	-295 Reduced 2.09%	13,800 $268,000
Q1 2023 May 09, 2023	SELL	$25.06 - $34.09 $9,297 - $12,647	-371 Reduced 2.56%	14,095 $399,000
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $3,821 - $6,084	153 Added 1.07%	14,466 $422,000
Q3 2022 Nov 18, 2022	SELL	$26.42 - $47.12 $5,099 - $9,094	-193 Reduced 1.33%	14,313 $378,000
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $3,011 - $3,748	73 Added 0.51%	14,506 $645,000
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $58,176 - $68,643	-1,305 Reduced 8.29%	14,433 $714,000
Q4 2021 Feb 15, 2022	BUY	$45.82 - $56.9 $10,721 - $13,314	234 Added 1.51%	15,738 $801,000
Q3 2021 Nov 15, 2021	SELL	$43.79 - $55.78 $27,456 - $34,974	-627 Reduced 3.89%	15,504 $865,000
Q2 2021 Aug 16, 2021	BUY	$36.86 - $44.5 $15,812 - $19,090	429 Added 2.73%	16,131 $690,000
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $30,789 - $37,888	-738 Reduced 4.49%	15,702 $731,000
Q2 2020 Aug 17, 2020	BUY	$43.24 - $55.02 $102,565 - $130,507	2,372 Added 16.86%	16,440 $789,000
Q1 2020 May 13, 2020	BUY	$34.37 - $60.07 $5,567 - $9,731	162 Added 1.16%	14,068 $647,000
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $20,750 - $24,566	-382 Reduced 2.67%	13,906 $835,000
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $88,092 - $110,470	-1,890 Reduced 11.68%	14,288 $796,000
Q1 2019 May 09, 2019	SELL	$38.66 - $51.82 $17,242 - $23,111	-446 Reduced 2.68%	16,178 $817,000
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $16,854 - $31,088	459 Added 2.84%	16,624 $670,000
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $15,462 - $19,455	232 Added 1.46%	16,165 $1.12 Million
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $192,187 - $287,325	3,750 Added 30.78%	15,933 $1.21 Million
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $39,120 - $50,145	-750 Reduced 5.8%	12,183 $642,000
Q4 2017 Feb 14, 2018	SELL	$49.6 - $60.87 $8,977 - $11,017	-181 Reduced 1.38%	12,933 $691,000
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $611,374 - $791,561	13,114	13,114 $782,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account